Zinc and cardiovascular risk in nephropathic patients undergoing hemodialysis treatment
Objective: To assess the relationship between zinc concentration and cardiovascular risk in patients with chronic renal failure on hemodialysis. Methods: Analytical retrospective cross-sectional study carried out in Fortaleza, Ceará, Brazil, in 2012 with 43 adult patients with chronic renal failure...
| Autores: | , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2018 |
| País: | Brasil |
| Recursos: | Universidade de Fortaleza (Unifor) |
| Repositorio: | Revista Brasileira em Promoção da Saúde |
| Idioma: | portugués inglés |
| OAI Identifier: | oai:ojs.ojs.unifor.br:article/5803 |
| Acesso em linha: | https://ojs.unifor.br/RBPS/article/view/5803 |
| Access Level: | acceso abierto |
| Palavra-chave: | Renal Insufficiency Chronic Zinc Renal Dialysis Cholesterol. Insuficiencia Renal Crónica Diálisis Renal Colesterol. Insuficiência Renal Crônica Zinco Diálise Renal |
| Resumo: | Objective: To assess the relationship between zinc concentration and cardiovascular risk in patients with chronic renal failure on hemodialysis. Methods: Analytical retrospective cross-sectional study carried out in Fortaleza, Ceará, Brazil, in 2012 with 43 adult patients with chronic renal failure on hemodialysis (HD group) and 35 healthy individuals (control group). Socioeconomic and biochemical (total cholesterol - TC, low density lipoprotein - LDL, very low density lipoprotein - VLDL, high density lipoprotein - HDL and triglycerides - TG) were collected. Plasma zinc was determined using coupled plasma optical emission spectrometry. HD group’ lipid profile was collected from medical records, and the controls’ lipid profile was analyzed using the Bioclin® kit. Non-HDL cholesterol was = CT – HDL-C. Cardiovascular risk was assessed using the TG/HDL ratio, with risk when >3.8. Student’s t test, Pearson’s test or Spearman’s test were used. Results: Zinc was below the recommended and lower (p |
|---|